A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Eisai Inc.
Eisai Inc.
AstraZeneca
Fate Therapeutics
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)